510(k) Report

FDA product code · General and plastic surgery

Extracorporeal Shock Wave Device For Treatment Of Diabetic Foot Ulcers

PZLClass II21 CFR 878.4685510(k) required8 decisions since 20170 recalls

8 FDA decisions since 2017. 510(k) reviews decided 2021–2025 took a median of 206 days (half between 110 and 208). No recall names this code. The most-cited predicate is K191961, named by 3 later devices.

Treatment of diabetic foot ulcers

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, general and plastic surgery panel

Twenty years of PZL at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · PZL

2in 2025

2017: 12019: 12020: 12021: 12023: 12024: 12025: 2
2007high 2 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PZL

Too few PZL 510(k)s in any year since 2007 to give a median.

Recalls per year · PZL

No recall names PZL since 2007.

Adverse event reports per year · PZL

No MAUDE report names PZL since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20171—00
20180—00
20191—00
20201—00
20211—00
20220—00
20231—00
20241—00
20252—00
20260—0—
FIG. 1 — PZL by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in PZL? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report